# Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions

Study · id `cardio:ct-nct02360423` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02360423](<https://clinicaltrials.gov/study/NCT02360423>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02360423

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 430 participants.

## Technical summary

Registry record NCT02360423. Randomized; no masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2016-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 430 participants (planned count; ClinicalTrials.gov record NCT02360423, source copy `cardio:ctgov-nct02360423-2015-03-25`, retrieved 2026-10-26)
- Start date: 2014-11 (registry gives no type) (ClinicalTrials.gov record NCT02360423, source copy `cardio:ctgov-nct02360423-2015-03-25`, retrieved 2026-10-26)
- Primary completion: 2016-10 (anticipated) (ClinicalTrials.gov record NCT02360423, source copy `cardio:ctgov-nct02360423-2015-03-25`, retrieved 2026-10-26)
- Completion: 2021-04 (anticipated) (ClinicalTrials.gov record NCT02360423, source copy `cardio:ctgov-nct02360423-2015-03-25`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02360423, source copy `cardio:ctgov-nct02360423-2015-03-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02360423-2015-03-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions
- Condition: Coronary Artery Disease
- Intervention (Device): CRE8 sirolimus-eluting stent
- Intervention (Device): RESOLUTE zotarolimus-eluting stent
- Lead sponsor: CID S.p.A.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 40dbaca1a90f6cb4d8def03706ca5e614f52a136207e2f8c9280b5c8b9976ddf
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
